Search research articles
Contact Us
Filters
Showing results (31-40 of 167) with videos related to
Page
of 17
Sort By:
The Annals of Thoracic Surgery
|
August 25, 2006
Effects of insulin-like growth factor-1 receptor inhibition in mesothelioma. Thoracic Surgery Directors Association Resident Research Award
Bryan A Whitson, Blake A Jacobson, Sandra Frizelle, et al.
Clinical Pharmacology in Drug Development
|
June 4, 2020
Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid Tumors
Chirag Patel, Sanjay Goel, Manish R Patel, et al.
Cancer Medicine
|
December 18, 2025
The Second Mitochondria-Derived Activator of Caspases Mimetic BI 891065 in Patients With Advanced Solid Tumors: Results From Two Phase I Studies
Manish R Patel, Erika P Hamilton, Ben George, et al.
Science Advances
|
September 19, 2025
Millefeuille: The layering of the Martian atmosphere observed in forward scattering geometry
Nicolas Thomas, Miguel Almeida, Omar Mokhtari, et al.
Archives of Pathology & Laboratory Medicine
|
March 4, 2011
Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues
Dhatri Kodali, Ajay Rawal, Mary J Ninan, et al.
Clinical Medicine Insights. Oncology
|
July 12, 2021
Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer
Shijia Zhang, Daniel F Pease, Amit A Kulkarni, et al.
Investigational New Drugs
|
January 10, 2009
Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase II
Ahad A Sadiq, Manish R Patel, Blake A Jacobson, et al.
The Oncologist
|
November 28, 2018
Phase I, First-in-Human, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors
Johanna C Bendell, Manish R Patel, Kathleen N Moore, et al.
Nature Communications
|
December 17, 2025
ER degradation for ER<sup>+</sup>/HER2- advanced or metastatic breast cancer: a phase 1 trial
Erika Hamilton, Rachel M Layman, David Cosgrove, et al.
Investigational New Drugs
|
July 27, 2011
Novel acridine-based agents with topoisomerase II inhibitor activity suppress mesothelioma cell proliferation and induce apoptosis
Ahmad Raza, Blake A Jacobson, Adam Benoit, et al.
Page
of 17
Search research articles
Search
Showing results (31-40 of 167) with videos related to
Sort By:
Page
of 17
The Annals of Thoracic Surgery
|
August 25, 2006
Effects of insulin-like growth factor-1 receptor inhibition in mesothelioma. Thoracic Surgery Directors Association Resident Research Award
Bryan A Whitson, Blake A Jacobson, Sandra Frizelle, et al.
Clinical Pharmacology in Drug Development
|
June 4, 2020
Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid Tumors
Chirag Patel, Sanjay Goel, Manish R Patel, et al.
Cancer Medicine
|
December 18, 2025
The Second Mitochondria-Derived Activator of Caspases Mimetic BI 891065 in Patients With Advanced Solid Tumors: Results From Two Phase I Studies
Manish R Patel, Erika P Hamilton, Ben George, et al.
Science Advances
|
September 19, 2025
Millefeuille: The layering of the Martian atmosphere observed in forward scattering geometry
Nicolas Thomas, Miguel Almeida, Omar Mokhtari, et al.
Archives of Pathology & Laboratory Medicine
|
March 4, 2011
Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues
Dhatri Kodali, Ajay Rawal, Mary J Ninan, et al.
Clinical Medicine Insights. Oncology
|
July 12, 2021
Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer
Shijia Zhang, Daniel F Pease, Amit A Kulkarni, et al.
Investigational New Drugs
|
January 10, 2009
Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase II
Ahad A Sadiq, Manish R Patel, Blake A Jacobson, et al.
The Oncologist
|
November 28, 2018
Phase I, First-in-Human, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors
Johanna C Bendell, Manish R Patel, Kathleen N Moore, et al.
Nature Communications
|
December 17, 2025
ER degradation for ER<sup>+</sup>/HER2- advanced or metastatic breast cancer: a phase 1 trial
Erika Hamilton, Rachel M Layman, David Cosgrove, et al.
Investigational New Drugs
|
July 27, 2011
Novel acridine-based agents with topoisomerase II inhibitor activity suppress mesothelioma cell proliferation and induce apoptosis
Ahmad Raza, Blake A Jacobson, Adam Benoit, et al.
Page
of 17